Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3143137
Max Phase: Preclinical
Molecular Formula: C34H62F2N3O8PS
Molecular Weight: 741.92
Molecule Type: Small molecule
Associated Items:
ID: ALA3143137
Max Phase: Preclinical
Molecular Formula: C34H62F2N3O8PS
Molecular Weight: 741.92
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCCCCCCSCC(COP(=O)(O)OC[C@H]1O[C@@H](n2ccc(N)nc2=O)C(F)(F)[C@@H]1O)OCCCCCCCCCC
Standard InChI: InChI=1S/C34H62F2N3O8PS/c1-3-5-7-9-11-13-14-16-18-20-24-49-27-28(44-23-19-17-15-12-10-8-6-4-2)25-45-48(42,43)46-26-29-31(40)34(35,36)32(47-29)39-22-21-30(37)38-33(39)41/h21-22,28-29,31-32,40H,3-20,23-27H2,1-2H3,(H,42,43)(H2,37,38,41)/t28?,29-,31-,32-/m1/s1
Standard InChI Key: FUNQYXZGWJEGQT-PRYODLOFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 741.92 | Molecular Weight (Monoisotopic): 741.3963 | AlogP: 8.03 | #Rotatable Bonds: 30 |
Polar Surface Area: 155.36 | Molecular Species: ACID | HBA: 11 | HBD: 3 |
#RO5 Violations: 3 | HBA (Lipinski): 11 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 1.89 | CX Basic pKa: | CX LogP: 8.36 | CX LogD: 5.98 |
Aromatic Rings: 1 | Heavy Atoms: 49 | QED Weighted: 0.05 | Np Likeness Score: 0.62 |
1. Alexander RL, Morris-Natschke SL, Ishaq KS, Fleming RA, Kucera GL.. (2003) Synthesis and cytotoxic activity of two novel 1-dodecylthio-2-decyloxypropyl-3-phosphatidic acid conjugates with gemcitabine and cytosine arabinoside., 46 (19): [PMID:12954073] [10.1021/jm020571x] |
Source(1):